CONCLUSIONS: Our data suggest that a reduction in functional anatomic V D may be the underlying mechanism for the benefits associated with UB in COPD patients. (ClinicalTrials.gov registration NCT00784004.)
CONCLUSIONS:Our data suggest that a reduction in functional anatomic V D may be the underlyingmechanism for the benefits associated with UB in COPD patients. (ClinicalTrials.gov registration NCT00784004.)